Paper3335948
Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome.
Ueda N and 7 others. J Pediatr, 1988. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome. Papers, record 3335948. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3335948
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nephrotic Syndrome | Major topic |
| Prednisolone | Major topic |
| Child | |
| Child, Preschool | |
| Drug Administration Schedule | |
| Female | |
| Follow-Up Studies | |
| Growth | |
| Humans | |
| Male | |
| Random Allocation |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40369478 | NR3C1 variants and glucocorticoid response in childhood nephrotic syndrome in North India. | BMC Nephrol | 2025 | https://conductscience.org/library/papers/40369478 | PubMed |
| 39171624 | Corticosteroid therapy for nephrotic syndrome in children. | Cochrane Database Syst Rev | 2024 | https://conductscience.org/library/papers/39171624 | PubMed |
| 35659203 | Corticosteroid therapy for nephrotic syndrome in children. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/35659203 | PubMed |
| 34307246 | Childhood Idiopathic Nephrotic Syndrome: Does the Initial Steroid Treatment Modify the Outcome? A Multicentre, Prospective Cohort Study. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34307246 | PubMed |
| 33774744 | Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis. | Eur J Pediatr | 2021 | https://conductscience.org/library/papers/33774744 | PubMed |
| 33611671 | Optimizing the corticosteroid dose in steroid-sensitive nephrotic syndrome. | Pediatr Nephrol | 2022 | https://conductscience.org/library/papers/33611671 | PubMed |
| 31335316 | Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation. | BMJ | 2019 | https://conductscience.org/library/papers/31335316 | PubMed |
| 27303658 | History of Nephrotic Syndrome and Evolution of its Treatment. | Front Pediatr | 2016 | https://conductscience.org/library/papers/27303658 | PubMed |
| 27195285 | Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children. | Biomed Res Int | 2016 | https://conductscience.org/library/papers/27195285 | PubMed |
| 25785660 | Corticosteroid therapy for nephrotic syndrome in children. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/25785660 | PubMed |
| 25653046 | Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. | Clin Exp Nephrol | 2015 | https://conductscience.org/library/papers/25653046 | PubMed |
| 25127916 | Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality. | Pediatr Nephrol | 2015 | https://conductscience.org/library/papers/25127916 | PubMed |
| 25054775 | A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment. | Kidney Int | 2015 | https://conductscience.org/library/papers/25054775 | PubMed |
| 23832139 | Uncertainty in management of childhood-onset idiopathic nephrotic syndrome: is the long-term prognosis really favorable? | Pediatr Nephrol | 2013 | https://conductscience.org/library/papers/23832139 | PubMed |
| 23371961 | Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome. | Clin J Am Soc Nephrol | 2013 | https://conductscience.org/library/papers/23371961 | PubMed |
| 21769641 | Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference? | Pediatr Nephrol | 2011 | https://conductscience.org/library/papers/21769641 | PubMed |
| 21399898 | Clinical course and outcome of children with steroid-sensitive nephrotic syndrome. | Pediatr Nephrol | 2011 | https://conductscience.org/library/papers/21399898 | PubMed |
| 19960305 | Evidence-based practice guideline for the treatment of CKD. | Clin Exp Nephrol | 2009 | https://conductscience.org/library/papers/19960305 | PubMed |
| 12716220 | The management of idiopathic nephrotic syndrome in children. | Paediatr Drugs | 2003 | https://conductscience.org/library/papers/12716220 | PubMed |
| 12700959 | Long versus standard initial steroid therapy for children with the nephrotic syndromeA report from the Southwest Pediatric Nephrology Study Group. | Pediatr Nephrol | 2003 | https://conductscience.org/library/papers/12700959 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3335948
GET https://conductscience.org/api/papers/v1/3335948/cited_by?page=2